Clinical Trial Detail


Missing content? – Request curation!

Request curation for specific Genes, variants, or PubMed publications.

Have questions, comments or suggestions? - Let us know!

Email us at :

NCT ID NCT03093155
Title Evaluation of Weekly Ixabepilone With or Without Biweekly Bevacizumab
Recruitment Active, not recruiting
Gender female
Phase Phase II
Variant Requirements No
Sponsors Yale University

ovary epithelial cancer

peritoneum cancer

fallopian tube cancer


Bevacizumab + Ixabepilone


Age Groups: adult | senior
Covered Countries USA

No variant requirements are available.